MYLAN ANNOUNCES FINAL APPROVAL FOR BISOPROLOL FUMARATE TABLETS

A A

Mylan Laboratories has received final FDA approval for its abbreviated new drug application for bisoprolol fumarate in 5- and 10-mg tablets. The product is the generic equivalent of Duramed Pharmaceuticals' beta-blocker Zebeta.